Development of lipidomic platform and phosphatidylcholine retention time index for lipid profiling of rosuvastatin treated human plasma

Biochemistry, Genetics and Molecular Biology

• Lipidomics 100%
• Retention Time 100%
• Blood Plasma 100%
• Lecithin 100%
• Rosuvastatin 100%
• Mobile Phase Composition 25%
• Chloroform 25%
• Drug Response 25%
• Lysophosphatidylcholine 25%
• Phosphatidylethanolamine 25%
• Phosphatidylinositol 25%
• Sphingomyelin 25%
• Time-of-Flight Mass Spectrometry 12%
• Ultra High Performance Liquid Chromatography 12%
• Blood Level 12%
• Biomembrane 12%
• Liquid Liquid Extraction 12%
• Phosphatidylserine 12%
• Phosphatidylglycerol 12%
• Lysophosphatidic Acid 12%

Chemistry

• Retention Time 100%
• Lecithin 100%
• Rosuvastatin 100%
• Methanol 25%
• Mobile Phase Composition 25%
• Triacylglycerol 25%
• Chloroform 25%
• Acetonitrile 25%
• Ammonium Acetate 25%
• Phosphatidylethanolamine 25%
• Sphingomyelin 25%
• Lysophosphatidylcholine 25%
• Phosphatidylinositol 25%
• Ultra Performance Liquid Chromatography 12%
• Phosphatidylserine 12%
• Quadrupole Time-of-Flight Mass Spectrometry 12%
• Sodium Chloride 12%
• Antilipemic Agent 12%
• Plasma Level 12%
• Salting Out 12%
• Solvent Extraction 12%
• Phosphatidylglycerol 12%
• Lysophosphatidic Acid 12%

Medicine and Dentistry

• Lipidomics 100%
• Rosuvastatin 100%
• Egg Lecithin 100%
• Methanol 25%
• Drug Response 25%
• Acetonitrile 25%
• Lysophosphatidylcholine 25%
• Mobile Phase Composition 25%
• Ammonium Acetate 25%
• Phosphatidylinositol 25%
• Chloroform 25%
• Phosphatidylethanolamine 25%
• Sphingomyelin 25%
• Side Effect 12%
• Hypolipidemic Agent 12%
• Ultra Performance Liquid Chromatography 12%
• Time-of-Flight Mass Spectrometry 12%
• 2 Propanol 12%
• Biomembrane 12%
• Phosphatidylserine 12%
• Lysophosphatidic Acid 12%
• Phosphatidylglycerol 12%